Literature DB >> 32788260

Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts.

Angelo M Taveira-DaSilva1, Simon R Johnson2, Patricia Julien-Williams1, Jan Johnson3, Mario Stylianou4, Joel Moss5.   

Abstract

Pregnancy in women with lymphangioleiomyomatosis (LAM) has been associated with increased complications and worsening lung function although objective data to advise patients are not available. We assessed lung function and CT scans before and after pregnancy in 16 women with LAM. During the pregnancy, pneumothorax was frequent and mean forced expiratory volume in 1 s (FEV1) fell from 77%±19% prepregnancy to 64%±25% predicted and DLCO from 66±26 to 57±26 (both p<0.01). After pregnancy, rates of FEV1 decline were high and 10 patients required sirolimus. Women with LAM, especially with moderate or advanced disease should be counselled regarding adverse events and loss of lung function during the pregnancy. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  rare lung diseases

Mesh:

Year:  2020        PMID: 32788260     DOI: 10.1136/thoraxjnl-2020-214987

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  2 in total

1.  Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM).

Authors:  Lisha Shen; Whenshuai Xu; Jinsong Gao; Jun Wang; Jiannan Huang; Yani Wang; Yudi He; Yanli Yang; Xinlun Tian; Kai-Feng Xu
Journal:  Orphanet J Rare Dis       Date:  2021-03-17       Impact factor: 4.123

2.  Family planning, pregnancy and birth in women with lung conditions: a worldwide survey.

Authors:  Clare Williams; Barbara Johnson; Peter G Middleton; Vibeke Backer; Peter G Gibson; Gill Hollis; Courtney Coleman
Journal:  ERJ Open Res       Date:  2021-12-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.